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YAP/TAZ regulates TGF-β/Smad3 signaling
by induction of Smad7 via AP-1 in human
skin dermal fibroblasts
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Abstract
Background: Transcription factors YAP and TAZ function as the primary mediators of the Hippo pathway. Yet,
crosstalk of YAP and TAZ with other signaling pathways remains relatively unexplored. We have explored the
impact of YAP and TAZ levels on the TGF-β/Smad signaling pathway in human skin dermal fibroblasts.
Methods: YAP and TAZ levels in dermal fibroblasts were reduced in dermal fibroblasts by siRNA-mediated knockdown.
The effects of YAP and TAZ reduction on TGF-β/Smad signaling were examined by quantitative real-time PCR, Western
analysis, and immunostaining. Luciferase reporter assays and electrophoretic mobility shift assays were conducted to
investigate the transcription factor DNA-binding and transcriptional activities.
Results: Knockdown of both YAP and TAZ (YAP/TAZ), but not either separately, impaired TGF-β1-induced Smad3
phosphorylation and Smad3 transcriptional activity, thereby inhibiting the expression of TGF-β target genes. This reduction
by reduced levels of YAP/TAZ results from induction of inhibitory Smad7, which inhibits Smad3 phosphorylation and
activity by TGF-β1. Conversely, prevention of Smad7 induction restores Smad3 phosphorylation and Smad3 transcriptional
activity in fibroblasts that have reduced YAP/TAZ. In agreement with these findings, inhibition of YAP/TAZ transcriptional
activity, similar to the reduction of YAP/TAZ levels, also significantly induced Smad7 and impaired TGF-β/Smad signaling.
Further investigations revealed that reduced levels of YAP/TAZ led to induction of activator protein-1 (AP-1) activity,
Activated AP-1 bound to DNA sequences in the Smad7 gene promoter, and deletion of these AP-1 binding sequences
substantially reduced Smad7 promoter reporter activity.
Conclusion: YAP/TAZ functions in concert with transcription factor AP-1 and Smad7 to regulate TGF-β signaling, in
human dermal fibroblasts. Reduction of YAP/TAZ levels leads to activation of AP-1 activity, which induces Smad7.
Smad7 suppresses the TGF-β pathway.
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Background
YAP and TAZ are central downstream effectors of the
Hippo signaling pathway, which plays a crucial role in
growth control, proliferation and tumor suppression [1, 2].
YAP and TAZ share substantial sequence homology and
often exert similar, overlapping functions. For these
reasons, they are often referred to together as YAP/TAZ.
YAP/TAZ activity is primarily regulated by sub-cellular
localization, which is responsive to cell-cell interactions
through the hippo pathway [3] or mechanical forces
through unknown mechanisms [4]. Retention of YAP/TAZ
in the cytoplasm, due to phosphorylation and/or binding to
other proteins inhibits nuclear translocation and transcrip-
tional co-activator function. Many aspects of YAP/TAZ
including its role in key cellular processes, regulation, and
mechanism of action as a transcriptional co-activator are
the subjects of intensive study. However, functional cross-
talk of YAP/TAZ with other signaling pathways and
transcription factors remain relatively unexplored.
TGF-β is a multifunctional cytokine that regulates nu-
merous developmental and homeostatic processes [5, 6].
TGF-βs initiate their cellular functions by binding to the
cell surface TGF-β receptor complex, which triggers
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activation of intracellular signaling molecules known as
Smads. There are three classes of Smad proteins: regula-
tory (R)-Smads, co-activator (Co)-Smads, and inhibitory
(I)-Smads. R-Smads (Smad2 and Smad3) are phosphory-
lated by the TGF-β type I receptor and form heteromeric
complexes with the Co-Smad, Smad4, which translocate
to the nucleus and bind to Smad-binding elements
(SBE) to regulate transcription of target genes. Phos-
phorylation of Smad2/3 by TGF-β receptor complexes is
antagonized by the endogenous inhibitory Smad, Smad7
[7, 8]. Expression of Smad7 is inducible by TGF-β itself,
and this induction plays a critical role in a negative feed-
back mechanism that regulates TGF-β/Smad biological
responses. Smad2 and Smad3 are the primary mediators
of TGF-β signaling. Aberrant expression of Smad7 could
upset the delicate balance inherent in TGF-β/Smad
signaling and thereby contribute to the pathophysiology
of certain human diseases. For example, in the fibrotic
disease scleroderma, the level of Smad7 expression has
been reported to be reduced [9]. This reduction could
permit unrestrained activation of the TGF-β/Smad
pathway, resulting in excess production and deposition
of collagen. Conversely, Smad7 has been reported to be
over-expressed in inflammatory bowel disease [10]. This
over-expression could down-regulate TGF-β-mediated
immunosuppression, resulting in hyper-secretion of
proinflammatory cytokines.
TGF-β/Smad pathway is also recognized as a pri-
mary regulator of extracellular matrix (ECM) homeo-
stasis [11, 12]. Deregulation of TGF-β signaling plays
a prominent role in the pathogenesis associated with
ECM proteins. For example, up-regulation of TGF-β
signaling causes abnormal accumulation of ECM
proteins in affected tissues, as seen in systemic
sclerosis (SSC), a chronic and progressive connective
tissue disease characterized by fibrosis of the skin and
internal organs [13, 14]. In contrast, TGF-β signaling
is often perturbed in aged human skin due to reduced
expression of TGF-β type II receptor (TβRII) and
Smad3 activation [12, 15]. Impaired TGF-β signaling
negatively regulates collagen homeostasis and has a
significant impact on human skin connective tissue
aging [12, 16]. As such, aberrant TGF-β signaling is
closely linked to the pathophysiology of broad human
diseases. Here we report that YAP/TAZ modulates
TGF-β/Smad3 pathway through a distinct mechanism
in human skin primary fibroblasts. Low levels of
YAP/TAZ or inhibition of YAP/TAZ nuclear trans-
location lead to up-regulation of Smad7 expression
via AP-1 transcription factor. Elevated Smad7, in turn,
inhibits Smad3 phosphorylation and impairs TGF-β/
Smad pathway. These data support the concept that
YAP/TAZ functions as an endogenous repressor of
Smad7 expression to modulate TGF-β signaling.
Methods
Materials
Dulbecco’s Modified Eagle’s Media (DMEM), αMEM,
GlutaMAX™, fetal calf sera, trypsin solution, penicillin/
streptomycin, and L-glutamine were purchased from Life
Technology (Rockville, MD). [γ-32p]ATP and [α-32p]dCTP
were obtained from New England Nuclear Life Science
Products (Boston, MA). Smad3, Smad7, CCN1/CTGF,
YAP, TAZ, and MMP-1 antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Phospho
Smad3 antibody for Fig. 1a was purchased from Cell
Signaling Technology (Danvers, MA). Phospho Smad3
antibody for Fig. 3d was purchased from Abcam
(Cambridge, MA). β-actin antibody was purchased from
Sigma Chemical Company (St. Louis, MO). RNA extrac-
tion kits were from Qiagen (Chatsworth, CA). Reagents
for real-time PCR were from Applied Biosystems (Foster
City, CA). Protein Assay Kit was from Bio-Rad Laborator-
ies (Hercules, CA). All other reagents were purchased
from Sigma Chemical Company (St. Louis, MO).
Cell culture and ethics statement
Human skin primary fibroblasts were cultured from
punch biopsy of healthy adult human skin, as described
previously [17]. Briefly, human skin punch biopsies from
sun-protected buttock (4 mm in diameter) were minced
into small pieces and then digested by collagenase
(5 mg/ml in αMEM) overnight at 37 °C. Tissue debris
from digested skin biopsies was removed by 100-μm
filters. Cells were cultivated in DMEM at 37 °C and 5%
CO2 supplemented with 10% Fetal Bovine Serum
(Sigma, MO). Cells were passaged no more than nine
times. Cells were plated at 70–80% confluence and used
one day later. All skin samples were obtained under a
protocol approved by the University of Michigan Institu-
tional Review Board. All volunteers provided written
informed consent. All methods were performed in
accordance with the relevant guidelines and regulations.
RNA isolation and quantitative real-time RT-PCR
Total RNA from human skin primary fibroblasts was
extracted using TRIzol reagent (Invitrogen, Carlsbad, CA).
Reverse transcription of total RNA (100 ng) was carried
out using a SYBR Green transcription kit (Applied Biosys-
tems, Foster City, CA). Real-time PCR was performed on
a 7300 Sequence Detector (Applied Biosystems,) using
TaqMan Universal PCR Master Mix Reagents (Applied
Biosystems,). All real-time PCR primers were purchased
from RealTimePrimers.com (Elkins Park, PA). Target gene
mRNA expression levels were normalized to the house-
keeping gene 36B4 (acidic ribosomal phosphoprotein P0)
[18] as an internal control for quantification.








Fig. 1 YAP/TAZ knockdown impairs TGF-β1-induced Smad3 phosphorylation and Smad Binding Element (SBE) luciferase reporter activity. Primary adult
human dermal fibroblasts were transfected with non-specific control siRNA or YAP and/or TAZ siRNAs (400 nM). 48 h after transfection, cells were
treated with vehicle (PBS) or TGF-β1 (5 ng/ml) for one hour and then whole cell extracts were prepared for analyses. a Protein levels of phospho-Smad3,
total Smad3, YAP, and TAZ were determined by Western blots. Images represent four independent experiments. Full-length blots are presented in
Additional file 1: Figure S2. b Quantification of Phospho-Smad3 protein levels. Protein levels were normalized by total Smad3. N= 4, *p< 0.05 vs TGF-β1
control. c Relative mRNA levels of YAP and TAZ in adult human primary dermal fibroblasts. N= 5. d Knockdown levels of YAP and TAZ mRNA by two
different sets of YAP and TAZ siRNAs. N= 3, *p< 0.05 vs CTRL siRNA. e Protein levels of total and phospho-Smad3 were determined by capillary
electrophoresis immunoassay and normalized to total Smad3. Band intensities were quantified by Compass software. Bands show representative digital
images. f YAP/TAZ knockdown inhibits TGF-β1-induced SBE luciferase reporter activity. Fibroblasts were co-transfected with non-specific control or YAP/
TAZ siRNAs (400 nM) and Smad Binding Element (SBE) luciferase reporter, and β-galactosidase expression vector. 32 h later, cells were treated with vehicle
(PBS) or TGF-β1 (5 ng/ml) for 16 h. SBE luciferase activities were determined 48 h after transfection and normalized to β-galactosidase activity. Bars indicate
fold change in SBE reporter activity relative to control siRNA. N= 3, *p< 0.05 vs control siRNA with TGF-β1. g Actin cytoskeleton disassembly inhibits YAP/
TAZ nuclear localization. Fibroblasts were treated with vehicle (DMSO) or latrunculin A (Lat-A, 30 nM) for 24 h and then F-actin was stained with phalloidin
(red), YAP/TAZ were immunostained (green), and nuclei were stained with DAPI (blue). Scale bars = 25 μm. All images are representative of three independent
experiments. h Actin cytoskeleton disassembly inhibits TGF-β1-induced Smad3 phosphorylation. Fibroblasts were treated with DMSO or Lat-A (30 nM) for
24 h, and then cells were treated with PBS or TGF-β1 (5 ng/ml) for one hour. Smad3 phosphorylation (p-Smad3) was determined by immunostaining (red).
Nuclei were stained with DAPI (blue). Scale bars = 25 μm. All images are representative of three independent experiments. All data are mean±SEM
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Transient transfection and luciferase assays
Human primary skin fibroblasts were transiently transfected
by electroporation (Amaxa, Koeln, Germany). Transient
transfection of Emerald Green Fluorescent Protein (EmGFP,
The Vivid Colors™ ThermoFisher Waltham, MA) indicated
that the transfection efficiency can be up to 80% in human
primary skin fibroblasts by electroporation. siRNAs for the
first set of YAP (GACAUCUUCUGGUCAGAGA) and
TAZ (AGGUACUUCCUCAAUCACA) si RNAs and
second set of YAP (CUGGUCAGAGAUACUUCUU) and
TAZ (ACGUUGACUUAGGAACUUU) were purchased
from Sigma Chemical Company (St. Louis, MO). The first
set (AGCUCAAUGAGCAUGUUUAGACUTT) and the
second set (ACAGCUCAAUUCGGACAACAAGAGT)
Smad7 siRNAs were purchased from Origene (Rockville,
MD). Smad3 siRNA (AATTCCTCGAGATAGGCCGTT)
was purchased from Qiagen-Xeragen (Germantown, MD),
and the specificity Smad3 antibody was confirmed by
Smad3 siRNA (Additional file 1: Figure S7). Control siRNA
(AATTGTCCGAACGTGTCACGT) were purchased from
Qiagen (Chatsworth, CA). After transfection (48 h), total
RNA and cellular protein were extracted, and mRNA and
protein levels were determined by real-time RT-PCR and
Western analysis, respectively, as described above. AP-1
reporter construct (pAP1-TA-Luc) was purchased from BD
Biosciences Clontech (Palo Alto, CA). Smad binding
element (SBE) luciferase reporter containing four repeti-
tions of the GTCTAGAC Smad3/4 binding motif (SBEX4)
was obtained from Bert Vogelstein of the Johns Hopkins
Oncology Center, Baltimore, MD. Smad7 promoter/lucifer-
ase construct (− 613 to + 112) or deletion constructs in the
binding sites of Smad3 and AP-1 were generously provided
Dr. Rainer Heuchel [19]. Cells were co-transfected with a β-
galactosidase expression vector, provide an internal standard
for transfection efficiency. Aliquots containing identical β-
galactosidase activity were used for each luciferase assay.
Luciferase activity was measured using an enhanced lucifer-
ase assay kit (PharMingen International, San Diego, CA)
according to the manufacturer’s protocol.
Western analysis
Human skin primary fibroblasts were scraped from the
culture dishes in WCE buffer (25 mM HEPES (pH 7.2),
75 mM NaCl, 2.5 mM MgCl2, 0.2 mM EDTA, 0.1% Triton
X-100, 0.5 mM DTT, 20 mM β-glycerophosphate, 0.1 mM
Na3VO4, 2 μg/ml leupeptin, and 100 μg/ml PMSF). The
cells were frozen/thawed/vortexed three times, and
whole-cell extracts were collected by centrifugation at
14,000×g for 10 min. Equal amounts of protein from
whole cell extracts were resolved on 10% SDS-
polyacrylamide gel (Invitrogen, CA) and transferred to
PVDF membrane (Millipore, Bedford, MA) overnight.
Next day, the membrane was blocked with PBST (0.1%
Tween 20 in PBS) containing 5% milk for one hour.
Primary antibodies were diluted in the PBST solution (1:
200) was incubated with PVDF membrane for one hour at
room temperature. Blots were washed three times with
PBST solution and incubated with appropriate secondary
antibody for one hour at room temperature. After washing
three times with PBST, the blots were developed with ECF
(Vistra ECFWestern Blotting System, Amersham Pharmacia
Biotech, Piscataway, NJ) following the manufacturer’s proto-
col. The intensities of each band were scanned by STORM
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
The intensities of each band were quantified using Image-
Quant (GE HealthCare, Piscataway, NJ) and normalized
using β-actin as a loading control.
ProteinSimple capillary electrophoresis immunoassay
In some experiments, due to the limit of sample volumes,
the protein levels were determined by ProteinSimple
capillary electrophoresis immunoassay. ProteinSimple
capillary electrophoresis immunoassay overcomes many
of the technical drawbacks of Western analysis, while pro-
viding much greater sensitivity, in the low nanogram
range. ProteinSimple capillary electrophoresis immuno-
assay was performed according to the ProteinSimple man-
ufacture’s user manual. In brief, whole cell extract samples
(800 ng/lane) were mixed with the kit provided master
mix. The mixture was then heated at 95 °C for 5 min. The
samples including primary antibodies, blocking reagent,
HRP-conjugated secondary antibodies, chemiluminescent
substrate, and separation and stacking matrices were also
dispensed to designated wells plate according to the Pro-
teinSimple manufacture’s user manual. The electrophor-
esis, blocking, washing, and immunodetection steps took
place in the capillary system (ProteinSimple Wes, Protein-
Simple, Santa Clare, CA) and were fully automated with
instrument default settings. Corresponding protein bands
from digital images were identified based on the molecular
weight. The intensities of each protein were analyzed by
quantification with Compass software (ProteinSimple)
after normalization by β-actin (loading control).
Immunohistology and phalloidin staining
Immunohistology was performed as described previously
[12]. Briefly, fibroblasts were fixed in 2% paraformalde-
hyde for one hour at room temperature and were incu-
bated with 0.5% Nonidet P-40 and then blocked with 2%
bovine serum albumin (BSA). The cells were washed with
PBS three times and incubated with primary antibodies
(YAP/TAZ and Smad7, Santa Cruz Biotechnology, Santa
Cruz, CA; Phospho Smad3, Abcam, Cambridge, MA) for
1 h at room temperature, followed by incubation with
Super Sensitive MultiLink (BioGenex, Fremont CA) for
10 min and streptavidin-conjugated AlexaFluor 594 or
488 (Invitrogen-Molecular Probes, San Diego, CA) for
10 min. Mounting medium with DAPI was added to stain
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cell nuclei. Corresponding IgG isotype (negative control)
show no specific staining (data not shown). For phalloidin
(Sigma, St. Louis, MO, USA) staining, fibroblasts were
washed with PBS and were fixed in 2% paraformaldehyde
for 30 min followed by phalloidin staining for one hour.
Electrophoretic mobility shift assay (EMSA)
EMSA were performed as described previously [20] using
nuclear extracts from human skin primary fibroblasts. Oli-
gonucleotides for EMSA probe, designed from the Smad7





cleotides were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). For competition experiments, a 50-fold
molar excess of cold competitors (AP-1 or SBE) were pre-
incubated with nuclear extract for 30 min on ice before la-
beled probes were added. The gel was transferred to 3MM
Whatman paper, vacuum-dried and scanned by STORM
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Statistical analysis
Comparisons among treatment groups were made with
the paired t-test (two groups) or the repeated measures
of ANOVA (more than two groups). Multiple pair-wise
comparisons were made with the Tukey Studentized
Range test. All p values are two-tailed and considered
significant when <0.05.
Results
YAP/TAZ knockdown impairs TGF-β1-induced Smad3
phosphorylation and Smad reporter activity
In the course of investigating the impact of YAP/TAZ
knockdown on the regulation of cell proliferation in
primary human dermal fibroblasts [21], we unexpectedly
observed substantial inhibition of TGF-β1-induced Smad3
phosphorylation (Fig. 1a and b). We observed that knock-
down of YAP or TAZ alone did not have any notable
effect on TGF-β1-induced Smad3 phosphorylation. In
contrast, combined knockdown of YAP and TAZ signifi-
cantly impaired TGF-β1-induced Smad3 phosphorylation.
This observation likely reflects compensatory actions of
YAP and TAZ. Consistent with this possibility, we found
that the levels of YAP and TAZ mRNA were similar, in
primary human dermal fibroblasts (Fig. 1c). Additionally,
to confirm the specificity of the effects of siRNA-mediated
knockdown of YAP and TAZ, we utilized a different set of
YAP and TAZ siRNAs (YAP/TAZ siRNAs#2) (Fig. 1d)
and found similar impairment of TGF-β1-induced Smad3
phosphorylation (Fig. 1e). In agreement with these data,
YAP/TAZ knockdown inhibited TGF-β1-induced Smad3
activity, measured by Smad binding element (SBE)
luciferase reporter assay (Fig. 1f). To further investigate the
mechanism by which YAP/TAZ knockdown inhibits activa-
tion of Smad3, we inhibited YAP/TAZ nuclear localization
by treatment of fibroblasts with latrunculin-A, which causes
disassembly of the actin cytoskeleton (Fig. 1g) [22]. Inhib-
ition of YAP/TAZ nuclear localization resulted in signifi-
cant reduction of TGF-β1-induced Smad3 phosphorylation
(Fig. 1h, top right panel), indicating that nuclear YAP/TAZ
is involved in regulation of TGF-β/Smad3 signaling.
Together, these data demonstrate that intact TGF-β/Smad3
signaling requires both YAP and TAZ in primary human
dermal fibroblasts.
YAP/TAZ knockdown inhibits TGF-β target gene
expression
To further explore the role of YAP/TAZ in TGF-β/Smad3
signaling, we investigated the effects of YAP and/or TAZ
knockdown on TGF-β target gene expression. In human
skin dermal fibroblasts, TGF-β is a potent stimulator of
CCN2 (also known as connective tissue growth factor,
CTGF) expression [12] We found that combined knock-
down of YAP and TAZ, but not separate knockdown of
YAP or TAZ, significantly reduced TGF-β1-induced CCN2
mRNA (Fig. 2a) and protein (Fig. 2b and c) levels. Similar
results were obtained with a different set of TAZ siRNAs
(YAP/TAZ siRNAs #2) (Fig. 2d). We also found that
combined YAP and TAZ knockdown reduced CCN2 levels
in the absence of added TGF-β (Fig. 2a-d), suggesting direct
regulation of CCN2, as previously reported [23, 24]. There-
fore, we investigated two other TGF-β target genes, JunB
[25–27] and hepatocyte growth factor (HGF) [28–30].
Combined knockdown of YAP and TAZ significantly re-
duced TGF-β1 induction of both JunB (Fig. 2e) and HGF
(Fig. 2f). These data further demonstrate that knockdown
of YAP/TAZ impairs TGF-β signaling, and thus inhibits
TGF-β target gene expression.
Knockdown of YAP/TAZ induces Smad7, an inhibitor of
TGF-β/Smad signaling
To explore the potential mechanism by which knock-
down of YAP/TAZ impairs TGF-β/Smad signaling, we
determined the effect of YAP/TAZ knockdown on
expression of the primary TGF-β pathway components,
such as TGF-β ligands, TGF-β receptors, and intracellu-
lar Smads. Interestingly, we found that YAP/TAZ knock-
down resulted in significant induction of Smad7, a
potent inhibitor of TGF-β signaling. Both Smad7 mRNA
(Fig. 3a) and protein (Fig. 3b) levels were induced. We
also observed that YAP/TAZ knockdown reduced
Smad3 mRNA expression (Fig. 3c), however, Smad3
protein levels were not altered (see Fig. 4b). No other
changes in TGF-β pathway components were observed
(Fig. 3c). We also observed that inhibition of YAP/TAZ
nuclear localization induced Smad7 mRNA and protein.
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Nuclear localization was inhibited by either Lat-A (Fig. 3d
and e), as described above (Fig. 1g and h), or by culture of
fibroblasts on poly-L-lysine (PLL) coated dishes (Fig. 3f
and g), which allows integrin-independent attachment and
limits cell spreading [31]. In either condition, inhibition of
YAP/TAZ nuclear translocation resulted in significant
induction of Smad7 protein and mRNA. Together, these
data demonstrate that knockdown of YAP/TAZ or inhib-
ition of YAP/TAZ nuclear translocation induces inhibitory
Smad7.
Induction of Smad7 by YAP/TAZ siRNA mediates impaired
TGF-β/Smad signaling
We next investigated whether induction of Smad7 is
responsible for inhibition of TGF-β signaling, which occurs
in response to knockdown of YAP/TAZ. We first confirmed
that Smad7 siRNA was able to efficiently inhibit induction
of Smad7 by YAP/TAZ knockdown (Fig. 4a). Importantly,
we found that knockdown of Smad7 was sufficient to pre-
vent inhibition of TGF-β1-induced Smad3 phosphorylation
in fibroblasts that have knockdown of YAP/TAZ (Fig. 4b
and c). In addition, prevention of Smad7 elevation signifi-
cantly restored SBE luciferase reporter activity in in fibro-
blasts with YAP/TAZ knockdown (Fig. 4d). Together, these
data demonstrate that knockdown of YAP/TAZ or inhib-
ition of YAP/TAZ nuclear translocation induces inhibitory
Smad7, which in turn impairs TGF-β/Smad signaling.
Knockdown of YAP/TAZ induces AP-1, the major driving
force for Smad7
Finally, we explored the mechanism by which knock-




Fig. 2 YAP/TAZ knockdown inhibits expression of TGF-β target genes CCN2, JunB, and HGF. Primary adult human dermal fibroblasts were trans-
fected with non-specific control siRNA or YAP and/or TAZ siRNAs (400 nM). 32 h after transfection, cells were treated with vehicle (PBS) or TGF-β1
(5 ng/ml) for 16 h. Whole cell extracts were prepared 48 h after transfection. a CCN2 mRNA levels. N = 4, *p < 0.05 vs CTRL siRNA, **p < 0.05 vs
CTRL siRNA with TGF-β1. b and c CCN2 protein levels. N = 3 *p < 0.05 vs CTRL siRNA, **p < 0.05 vs CTRL siRNA with TGF-β1. Full-length blots are
presented in Additional file 1: Figure S3. d CCN2 mRNA levels are reduced by YAP/ TAZ siRNA #2. N = 3, *p < 0.05 vs CTRL siRNA, **p < 0.05 vs
CTRL siRNA with TGF-β1. e JunB mRNA levels. N = 3, *p < 0.05 vs CTRL siRNA with TGF-β1. f HGF mRNA levels. N = 3, *p < 0.05 vs CTRL siRNA with
TGF-β1. mRNA levels were quantified by real-time RT-PCR and normalized to mRNA for housekeeping gene 36B4. Protein levels were determined
by Western blots. Protein levels were normalized by β-actin as a loading control. All data are mean±SEM







Fig. 3 (See legend on next page.)
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gene promoter contains binding sites for Smad3 and
activator protein-1 (AP-1) (Fig. 5a) [19, 32]. In human
dermal fibroblasts, these two transcription factors act
independently to regulate Smad7 expression. Smad3
stimulates Smad7 expression in response to TGB-β,
while AP-1 stimulates Smad7 in response to exposure to
ultraviolet irradiation [31]. Since knockdown of YAP/
TAZ impairs Smad3 activity, we investigated whether
knockdown of YAP/TAZ leads to increased AP-1
activity. Indeed, knockdown of YAP/TAZ significantly
elevated AP-1 reporter activity (Fig. 5b). Knockdown of
YAP/TAZ also increased expression of matrix
metalloproteinase-1 (MMP-1) (Fig. 5c and d), which is
well-characterized AP-1 target gene. To examine the
role AP-1 in Smad7 induction, Smad7 proximal
promoter luciferase reporter constructs, containing the
AP-1 and the Smad3 binding sites, were transiently
transfected into fibroblasts with and without YAP/TAZ
knockdown. Knockdown of YAP/TAZ resulted in signifi-
cant activation (3.4-fold) of Smad7 promoter activity,
and this activation was nearly abolished by deletion of
the AP-1 binding site, while deletion of the Smad3 bind-
ing site had no effect (Fig. 5e).
We next investigated whether knockdown of YAP/
TAZ increases the binding to the AP-1 element in the
Smad7 gene promoter, using electrophoretic mobility
shift assays (EMSA). The double-stranded DNA probe
containing the AP-1 binding sequence in the Smad7
promoter is shown in Fig. 5a (underlined). As shown in
Fig. 5f, knockdown of YAP/TAZ resulted in substantial
increase binding to the AP-1/Smad7 probe (lane 2). This
complex was substantially reduced by excess unlabeled
consensus AP-1 probe (Fig. 5f, lane 3), but not by the
mutant AP-1 probe (Fig. 5f, lane 4), indicating that bind-
ing was specific. As expected, knockdown of YAP/TAZ
significantly decreased Smad 3 binding to the SBE probe
of the Smad7 promoter (Fig. 5g). This finding is consist-
ent lack of effect of removal of the SBE in the Smad7
promoter (Fig. 5e) and impairment of TGB-β/Smad3
signaling (Figs. 1, 2 and 3) by knockdown of YAP/
TAZ. Together these data indicate that knockdown of
YAP/TAZ induces AP-1, which in turn mediates
induction of Smad7.
Discussion
Several recent studies have demonstrated cross-talk be-
tween YAP/TAZ and the TGF-β pathway. For example,
nuclear YAP and TAZ have been found to physically and
functionally interact with Smad transcriptional complexes
to modulate their activity [33, 34] and stability, through
ubiquitin-mediated degradation [35, 36]. In addition,
YAP/TAZ have also been reported to interact with Smad7,
and thereby potentiate its inhibitory activity [35, 36].
Thus, YAP/TAZ can modulate TGF-β/Smad pathway
through interaction with Smads complexes. Our data re-
veal a distinct mechanism of cross-talk between YAP/TAZ
and TGF-β/Smad signaling that involves transcriptional
regulation of Smad7 expression. We found that knock-
down of YAP/TAZ or inhibition of YAP/TAZ nuclear
localization reduces Smad3 phosphorylation and activity.
This inhibition results from up-regulation of Smad7 via an
AP-1-dependent mechanism.
TGFβ family members regulate diverse physiological and
pathological events through Smad proteins, the central
modulators of TGF-β signaling. Although Smad7 induction
by TGF-β itself is well characterized, the mechanisms
underlying Smad7 regulation by other pathways are incom-
pletely understood. Our data indicate that YAP/TAZ
functions as an endogenous repressor of Smad7 gene
expression, in human dermal fibroblasts. This conclusion is
consistent with the relative levels of YAP/TAZ and Smad7
observed in both human dermis (Additional file 1: Figure
S1A) and human primary human dermal fibroblasts
(Additional file 1: Figure S1B).
We found that combined knockdown of YAP and TAZ,
but not separate knockdown, induced Smad7 and impairs
TGF-β signaling. Also, separate knockdown of YAP or TAZ
did not result in induction of the other. These findings
(See figure on previous page.)
Fig. 3 Knockdown of YAP/TAZ or inhibition of YAP/TAZ nuclear localization induces inhibitory Smad7. Primary adult dermal fibroblasts were
transfected with non-specific control or YAP/TAZ siRNAs (400 nM). Whole cell extracts were prepared 48 h after transfection. a Smad7 mRNA
levels. mRNA levels were quantified by real-time RT-PCR. mRNA levels were normalized to mRNA for housekeeping gene 36B4. N = 5, *p < 0.05 vs
CTRL siRNA. b Smad7 protein levels. Protein levels were determined by Western blot and normalized by β-actin (loading control). N = 3, *p < 0.05
vs CTRL siRNA. Full-length blots are presented in Additional file 1: Figure S4. c TGF-β pathway components mRNA expression. N = 3–6. d Actin
cytoskeleton disassembly induces Smad7 protein. Primary adult human dermal fibroblasts were treated with vehicle (DMSO) or latrunculin A
(Lat = A, 30 nM) for 24 h, and then cells were immunostained for Smad7 (top panel, green), YAP/TAZ (middle panel, green), and phalloidin (lower
panel, red). Nuclei were stained with DAPI (blue). Scale bars = 25 μm. The staining intensities and cell surface areas were quantified by ImageJ
software. *p < 0.05 vs DMSO. All images are representative of three independent experiments. e Actin cytoskeleton disassembly induces Smad7
mRNA. mRNA levels were quantified by real-time RT-PCR and normalized to mRNA for housekeeping gene 36B4. N = 3, *p < 0.05 vs DMSO. f Limiting
cell spreading induces Smad7 protein. Fibroblasts were plated on standard tissue culture plates (left panels) or poly-L-lysine (PLL) coated plates (right
panels). 24 h later, cells were immunostained for Smad7 (top panel, green), YAP/TAZ (middle panel, green), and phalloidin (low panel, red). Nuclei were
stained with DAPI (blue). Scale bars = 25 μm. The staining intensities and cell surface areas were quantified by ImageJ software. *p < 0.05 vs standard
tissue culture plate. All images are representative of three independent experiments. g Limiting cell spreading induces Smad7 mRNA. mRNA levels
were quantified by real-time RT-PCR and normalized to mRNA for housekeeping gene 36B4. N = 3, *p < 0.05 vs DMSO. All data are mean±SEM
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likely reflect compensatory effects of YAP and TAZ on
Smad7 expression. YAP and TAZ have highly homologous
structures and redundancy of functions is not unexpected.
A recent ChIP-seq analysis of genome-wide promoter and
enhancer regions found that the binding sites of YAP and
TAZ largely overlap with each other [37].
Our findings raise an interesting question regarding the
mechanism by which reduction of YAP/TAZ leads to up-
regulation of AP-1 activity. YAP/TAZ knockdown did not
significantly alter expression levels of AP-1 family (JUN
and FOS proteins) members (Additional file 1: Figure S6).
The AP-1 family member JunB is regulated by TGF-β/
Smad3 and silencing of YAP/TAZ reduced TGF-β-
induced JunB expression (Fig. 2e). These data indicate that
JunB is not required for up-regulation of AP-1 activity,
which results from knockdown of YAP/TAZ. This conclu-
sion is consistent with our previous findings that c-Jun
and c-Fos are the principal components of the AP-1 com-
plex in human skin [38–40]. In human skin primary fibro-
blasts, many AP-1 target genes, such as multiple MMPs,
are largely regulated by c-Jun [41, 42]. In addition to
transcription, AP-1 activity is regulated by dimer compos-
ition, post-translational modifications, and interactions





Fig. 4 Knockdown of Smad7 reverses inhibition of TGF-β/Smad3 signaling by YPA/TAZ silencing. a Reduction of elevated Smad7 by siRNA-mediated
knockdown. Smad7 protein levels were determined by ProteinSimple capillary electrophoresis immunoassay. Data are representative of two independent
experiments. b and c Restoration of TGF-β1-induced Smad3 phosphorylation by Smad7 knockdown. Fibroblasts were transfected with the indicated siRNAs
and 48 h treated with TGF-β1 (5 ng/ml) for 1 h. Protein levels of total Smad3, phospho-Smad3, and beta-actin (loading control) were determined by
ProteinSimple capillary electrophoresis immunoassay. N= 2, *p< 0.05 vs CTRL siRNA with TGF-β1, **p< 0.05 vs YAP/TAZ siRNA with TGF-β1. d Restoration
of TGF-β/Smad3 activity by Smad7 knockdown. Fibroblasts were co-transfected with non-specific control or YAP/TAZ siRNAs (400 nM) and/or Smad7
siRNAs along with Smad Binding Element (SBE) luciferase reporter and β-galactosidase expression vector. 32 h later, cells were treated with vehicle (PBS)
or TGF-β1 (5 ng/ml) for 16 h. SBE luciferase activities were determined 48 h after transfection and normalized to β-galactosidase activity. Bars indicate fold
change in SBE reporter activity relative to control siRNA. N= 3, *p< 0.05 vs control siRNA with TGF-β1,**p< 0.05 vs YAP/TAZ siRNA with TGF-β1. All data are
expressed as mean±SEM






Fig. 5 (See legend on next page.)
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involved in regulation of AP-1 activity by YAP/TAZ
remains to be determined.
Interestingly, a recent study has reported that YAP
expression is regulated by c-Jun [44]. Transient transfec-
tion of c-Jun significantly increased YAP mRNA levels.
Conversely, YAP mRNA levels were markedly reduced in
c-Jun deficient cells. Retroviral-mediated re-introduction
of c-Jun restored YAP mRNA expression levels. Moreover,
a recent study demonstrated that YAP/TAZ/TEAD and
AP-1 form a complex in the nucleus that synergistically
activates target genes involved in oncogenic growth [37].
Thus, emerging data demonstrate that AP-1 is involved in
both YAP/TAZ expression and function. Our data extend
these observations by revealing that lower levels of YAP/
TAZ enhance AP-1 activity. Given the functional coopera-
tivity between YAP/TAZ and AP-1, one may speculate
that reduction of YAP/TAZ leads to a compensatory
increase of AP-1 activity, in dermal fibroblasts.
Conclusions
YAP/TAZ knockdown or inhibition of YAP/TAZ nuclear
localization induces Smad7 via activation of AP-1, which
in turn impairs TGF-β/Smad signaling (Fig. 5h). These
data reveal a new mechanism for cross-talk between
YAP/TAZ TGF-β signaling pathways.
Additional file
Additional file 1: Figure S1. Smad7, YAP, and TAZ mRNA expression
in human skin dermis in vivo and primary dermal fibroblasts in vitro. (A)
Human skin dermis was prepared by cutting off epidermis at a depth of
1 mm by cryostat. Dermal total RNA was prepared using a commerical kit
(RNeasy midikit, Qiagen, Chatsworth, CA). N = 8. (B) Total RNA from primary
dermal dibroblasts was extracted using TRIzol reagent (Invitrogen, Carlsbad,
CA). N = 3 mRNA levels for Smad7, YAP, and TAZ were determined by real-
time RT-PCR. mRNA levels were normalized to mRNA for 36B4, a ribosomal
protein used as an internal control for quantitation. Data are expressed as
mean + SEM, *p < 0.05 vs Smad7. Figure S2. Full-length Western blots for
Fig. 1a. Figure S3. Full-length Western blots for Fig. 2b. Figure S4. Full-
length Western blots for Fig. 3b. Figure S5 A. Full-length Western blots for
Fig. 5d. B. Full-length Western blots for Fig. 5f. C. Full-length Western blots
for Fig. 5g. Figure S6 YAP/TAZ knockdown did not alter AP-1 family
transcription factors mRNA expression. Primary dermal fibroblasts were
transfected with non-specific control siRNA or YAP/TAZ siRNAs (400 nM)
for 48 h. AP-1 family transcription factors mRNA levels were quantified by
real-time RT-PCR. mRNA levels were normalized to mRNA for 36B4, a
ribsomal protein used as an internal control for quantitation. N = 4, data are
expressed as mean + SEM. Figure S7. Smad3 antibody specificity testing by
Smad3. Primary dermal fibroblasts were transfected with with non-specific
control siRNA or Smad3 siRNA (400 nM). 48 h after transfection, cells were
treated with TGF-β1 (ng/ml) for one hour and whole cell extract was
prepared. Protein levels of phospho-Smad3 were determined by Capillary
electrophoresis immunoassay and normalized to β-actin (loading control).
Band intensities were quantified by Compass software. Bands show
representative digital images. (PDF 175 kb)
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Fig. 5 Induction of Smad7 by knockdown of YAP/TAZ is mediated by AP-1. a Nucleotide sequence of the Smad7 proximal promoter. Smad Binding
Element (SBE) and Activator Protein 1 (AP-1) binding sites are marked in capital letters. Heavy lines under the sequence denote EMSA probes containing
SBE and AP-1 binding elements. Arrow indicates transcription start site. b Primary adult human dermal fibroblasts were co-transfected with non-specific
control or YAP/TAZ siRNAs (400 nM), AP-1 reporter construct, and β-galactosidase expression vector. AP-1 reporter activities were determined 48 h after
transfection and normalized to β-galactosidase activity. N= 3, *p< 0.05 vs control siRNA. c and d Fibroblasts were co-transfected with non-specific control
or YAP/TAZ siRNAs (400 nM). Whole cell extracts were prepared 48 h after transfection. c MMP-1 mRNA levels and (d) MMP-1 protein levels were analyzed
by real-time RT-PCR and Western blot, respectively. mRNA levels were normalized to mRNA for housekeeping gene 36B4. Full-length Western blots are
presented in Additional file 1: Figure S5A. *p< 0.05 vs control siRNA. e Fibroblasts were co-transfected with non-specific control or YAP/TAZ siRNAs
(400 nM), wild-type (− 613 to + 112) or mutant Smad7 promoter/luciferase reporter constructs as depicted in the figure, and β-galactosidase expression
vector. Smad7 promoter luciferase activities were determined 48 h after transfection and normalized to β-galactosidase activity. Bars indicate fold change
of Smad7 promoter activity relative to control siRNA. N= 3–5, *p< 0.05 vs control siRNA. f and g Fibroblasts were transfected with non-specific control or
YAP/ TAZ siRNAs (400 nM) for 48 h. Nuclear extracts were prepared, and DNA/protein complex formation was analyzed by EMSA using AP-1 (f) and SBE
(g) probes, as indicated in Fig. 5a (underlined). Closed triangles indicate specific retarded complexes. Open triangle indicates non-specific bands. Arrow
indicates Smad3 super-shift band. Results are representative of three experiments. Full-length images are presented in Additional file 1: Figure S5B and S5C.
All data are expressed as mean±SEM. h Schematic of cross-talk between YAP/TAZ and TGF-β/Smad pathways involving AP-1 regulation of Smad7
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